Safety and effectiveness of mirogabalin for CIPN induced by nab-paclitaxel in patients with pancreatic cancer

被引：0
|
作者：
Saito, Kei [1 ]
Nakai, Yousuke [1 ,2 ]
Ishigaki, Kazunaga [1 ]
Takahara, Naminatsu [1 ]
Suzuki, Tatsunori [1 ]
Hakuta, Ryunosuke [1 ,2 ]
Saito, Tomotaka [1 ]
Hamada, Tsuyoshi [1 ]
Mizuno, Suguru [1 ]
Kogure, Hirofumi [1 ]
Fujishiro, Mitsuhiro [1 ]
机构：
[1] Univ Tokyo, Dept Gastroenterol, Grad Sch Med, Tokyo, Japan
[2] Univ Tokyo, Dept Endoscopy & Endoscop Surg, Grad Sch Med, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.05.262
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P21-17
引用
下载
收藏
页码：S520 / S520
页数：1
相关论文
共 50 条
  • [1] nab-Paclitaxel for the treatment of pancreatic cancer
    Kim, George
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 85 - 96
  • [2] Histopathological Changes of Pancreatic Cancer Stroma Induced by nab-Paclitaxel
    Ishido, K.
    Kudo, D.
    Kimura, N.
    Wakiya, T.
    Hakamada, K.
    PANCREAS, 2018, 47 (10) : 1395 - 1395
  • [3] Effectiveness and safety of nab-paclitaxel/gemcitabine in locally advanced or metastatic pancreatic adenocarcinoma
    Nebot-Villacampa, Maria-Jose
    Zafra-Morales, Ricardo
    Alfaro-Olea, Ascension
    Marin-Gorricho, Raquel
    Casajus-Navasal, Andrea
    Uriarte-Pinto, Moises
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (03) : 603 - 611
  • [4] Nab-paclitaxel utilization pattern and safety profile in patients with metastatic breast and pancreatic cancer
    Cortes de Miguel, S.
    Ruiz Fuentes, S.
    Belda Rustarazo, S.
    Valle Corpas, M.
    Casas Hidalgo, I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 507 - 507
  • [5] Efficacy and safety of Nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer
    Filipazzi, V.
    Dalu, D.
    Isabella, L.
    Tosca, N.
    Ferrario, S.
    Gambaro, A.
    Somma, L.
    Fasola, C.
    Pellegrini, I.
    Bombonati, G.
    Curcio, R.
    Damiani, E.
    Cattaneo, M. T.
    ANNALS OF ONCOLOGY, 2017, 28
  • [6] EFFICACY AND SAFETY OF NAB-PACLITAXEL IN COMBINATION WITH GEMCITABINE FOR METASTATIC PANCREATIC CANCER
    You, Min Su
    Ryu, Ji Kon
    Kang, Jinwoo
    Choi, Jin Ho
    Choi, Young Hoon
    Huh, Gunn
    Paik, Woo Hyun
    Lee, Sang Hyub
    Kim, Yong-Tae
    GASTROENTEROLOGY, 2018, 154 (06) : S285 - S285
  • [7] Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer
    De Luca, Rossella
    Blasi, Livio
    Alu, Massimiliano
    Gristina, Valerio
    Cicero, Giuseppe
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1769 - 1775
  • [8] Nab-paclitaxel and gemcitabine for the treatment of patients with metastatic pancreatic cancer
    Borazanci, Erkut
    Von Hoff, Daniel D.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 8 (07) : 739 - 747
  • [9] Safety and Efficacy of nab-Paclitaxel in the Treatment of Patients with Breast Cancer
    Vishnu, Prakash
    Roy, Vivek
    BREAST CANCER-BASIC AND CLINICAL RESEARCH, 2011, 5 : 53 - 65
  • [10] Nab-paclitaxel shows promise in pancreatic cancer
    Baker, Holly
    LANCET ONCOLOGY, 2013, 14 (13): : E585 - E585
12345